XY4-58521-13892
3 vaccinations
4 coded responses
28 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 018 / MA
- Registered
- 2021-01-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-29
Registered in v-safe
-
2021-01-29
Dose 1 — Pfizer-BioNTech
- 2021-01-29
- 2021-01-30
- 2021-01-31
-
2021-02-01
Survey response — days 1–6 daily, dose 1MedDRA: Arthralgia, Pre-existing disease — Feeling: Fair · Site: Pain · Joint pains · Be unable to do your normal daily activitiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-02-02
Survey response — days 1–6 daily, dose 1MedDRA: Arthralgia — Feeling: Fair · Site: Pain · Joint pains · Be unable to do your normal daily activitiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-02-03
- 2021-02-04
- 2021-02-05
-
2021-02-19
Dose 2 — Pfizer-BioNTech
- 2021-02-19
-
2021-02-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body achesAdult check-in
- 2021-02-21
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-02-25
- 2021-02-26
- 2021-03-07
- 2021-03-14
- 2021-03-19
- 2021-03-26
- 2021-04-02
- 2021-05-23
- 2021-08-20
-
2022-04-01
Dose 3 — Pfizer-BioNTech
- 2022-04-23
- 2022-04-29
- 2022-05-06
-
2022-05-13
Survey response — 42 day, dose 3MedDRA: Cough, Dry throat, Headache, Nasal congestion, SARS-CoV-2 test positive, Throat irritation — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11 · check-in answers available
-
2022-05-13
Report sent to call center — 42 day, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-05-16
-
2022-07-01
Survey response — 3 month, dose 3MedDRA: Arthralgia, Decreased appetite, Pre-existing disease — Feeling: GoodMedDRA releases: 2024-11 · check-in answers available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-29 | Pfizer-BioNTech | |
| 2 | 2021-02-19 | Pfizer-BioNTech | |
| 3 | 2022-04-01 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-05-13 | Unsuccessful |
Free text
Release 3
Systemic reaction (other): Just clarifying my symptoms: my joint pain was only specific joints, one of which has been injured in the past. Its also snowing heavily and that has contributed to pain the past. Its possible that the pain is soreness from the shot but I dont believe its the only contributing factor
Systemic reaction (other): Joint pains still specific to certain joints (not generalized).
Release 11
Symptoms: Scratchy/dry throat, nasal congestion, headache, cough (recent positive COVID test)
Release 12
Symptoms: Some loss of appetite, joint pain (difficult to discern from existing issues though)
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Decreased appetite | · | · | ✓ |
| SD | Dry throat | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Throat irritation | · | · | ✓ |
| SRO | Arthralgia | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release